Glaxo Smithkline

[riskreturn]

GLAXO SMITHKLINE CONSUMER NIGERIA PLC
UNAUDITED RESULT FOR HALF YEAR ENDED 30-06-2008
2008 2007
TURNOVER N6.025b N4.372b
PROFIT BEFORE TAXATION N1.139b N485.141m
TAXATION (N353.242m) (N150.394m)
PROFIT AFTER TAXATION N786.051m N334.747m

[BLUEMONEY]

Originally Posted by riskreturn

GLAXO SMITHKLINE CONSUMER NIGERIA PLC
UNAUDITED RESULT FOR HALF YEAR ENDED 30-06-2008
2008 2007
TURNOVER N6.025b N4.372b
PROFIT BEFORE TAXATION N1.139b N485.141m
TAXATION (N353.242m) (N150.394m)
PROFIT AFTER TAXATION N786.051m N334.747m

Very Impressive.

[panasharp]

Is the company on suspension?

[hispy99]

Originally Posted by panasharp

Is the company on suspension?

Not that I know of....close price has just not changed, but you'll notice that high and lows are different from close price, suggesting that it is not on suspension.

[billions]

4TH QTR FORECAST P&L ACCTS INFO 2008
GLAXOSMITHKLINE PLC, PERIOD ENDED 31-12-2008 (4TH QUARTER) FORECAST PPROFIT AND LOSS ACCTS INFORMATION 2008

TURNOVER 08 N12.353b

PROFIT BEFORE TAXATION 08 N1.535b

FORECAST TAXATION 08 (N468m)

PROFIT AFTER TAXATION 08 N1.067b

[mosbe]

http://allafrica.com/stories/200812220159.htm

[zainabusman]

Originally Posted by billions

4TH QTR FORECAST P&L ACCTS INFO 2008
GLAXOSMITHKLINE PLC, PERIOD ENDED 31-12-2008 (4TH QUARTER) FORECAST PPROFIT AND LOSS ACCTS INFORMATION 2008

TURNOVER 08 N12.353b

PROFIT BEFORE TAXATION 08 N1.535b

FORECAST TAXATION 08 (N468m)

PROFIT AFTER TAXATION 08 N1.067b

GLAXOSMITHKLINE CONSUMER NIGERIA PLC
PERIOD ENDED 31ST DECEMBER 2008
PROFIT AND LOSS ACCOUNTS INFORMATION
2008 2007
TURNOVER N12.545b N9.915b
PROFIT BEFORE TAXATION N1.851b N1.166B
TAXATION (N573.923m) (N329.572m)
PROFIT AFTER TAXATION N1.277b N836.876b
BALANCE SHEET INFORMATION
FIXED ASSETS N3.961b N3.515b
STOCK N2.539b N2.543b
TRADE DEBTORS N1.864b N2.147b
CASH AND BANK BALANCES N1.244b N512.329m
TRADE CREDITS N68.606m N596.947m
SHORT TERM BORROWINGS N0.00 N58.122m
OTHER CREDIT BALANCES N4.089b N3.273b
WORKING CAPITAL N2.327b N1.871b
NET ASSETS N5.451b N4.601b
PROPOSED DIVIDEND N0.60 PER SHARE AGM DATE MAY 21ST 2009
CLOSURE OF REGISTER APRIL 27TH TO MAY 4TH 2009
PAYMENT DATE MAY 21ST 2009 AGM THURSDAY 21ST MAY 2009
AT THE SHELL NIGERIA HALL MUSON CENTRE ONIKAN
LAGOS AT 11.00a.m

The full year result is better than the forecast. The price fell today!

[zainabusman]

Originally Posted by zainabusman

GLAXOSMITHKLINE CONSUMER NIGERIA PLC
PERIOD ENDED 31ST DECEMBER 2008
PROFIT AND LOSS ACCOUNTS INFORMATION
2008 2007
TURNOVER N12.545b N9.915b
PROFIT BEFORE TAXATION N1.851b N1.166B
TAXATION (N573.923m) (N329.572m)
PROFIT AFTER TAXATION N1.277b N836.876b
BALANCE SHEET INFORMATION
FIXED ASSETS N3.961b N3.515b
STOCK N2.539b N2.543b
TRADE DEBTORS N1.864b N2.147b
CASH AND BANK BALANCES N1.244b N512.329m
TRADE CREDITS N68.606m N596.947m
SHORT TERM BORROWINGS N0.00 N58.122m
OTHER CREDIT BALANCES N4.089b N3.273b
WORKING CAPITAL N2.327b N1.871b
NET ASSETS N5.451b N4.601b
PROPOSED DIVIDEND N0.60 PER SHARE AGM DATE MAY 21ST 2009
CLOSURE OF REGISTER APRIL 27TH TO MAY 4TH 2009
PAYMENT DATE MAY 21ST 2009 AGM THURSDAY 21ST MAY 2009
AT THE SHELL NIGERIA HALL MUSON CENTRE ONIKAN
LAGOS AT 11.00a.m

The full year result is better than the forecast. The price fell today!

The EPS is roughly N1.33. That gives a PE of 11.5 at today's price. The fall is therefore not surprising given current mkt PE's. The dividend is 60 kobo an improvement on last year but not good enough at a yield of only 3.9%.

[BLUEMONEY]

Originally Posted by zainabusman

The EPS is roughly N1.33. That gives a PE of 11.5 at today's price. The fall is therefore not surprising given current mkt PE's. The dividend is 60 kobo an improvement on last year but not good enough at a yield of only 3.9%.

True talk, That P.E is just too much compared to other stocks in the market.

[tonidol]

Originally Posted by zainabusman

The EPS is roughly N1.33. That gives a PE of 11.5 at today's price. The fall is therefore not surprising given current mkt PE's. The dividend is 60 kobo an improvement on last year but not good enough at a yield of only 3.9%.

60k dividend for a stock trading around N15 is poor in the present circumstance on the NSE. Some N4 or less stocks can deliver such abeg.

[billions]

GLAXOSMITHKLINE PLC
FIRST QUARTER RESULT PERIOD ENDED 31ST MARCH 2009
PROFIT AND LOSS ACCOUNTS INFORMATION
2009 2008 %CHANGE
TURNOVER N3.874b N2.968b 31
PROFIT BEFORE TAXATION N865.256m N588.260m 47
TAXATION (N271.329m) (N182.383m) 49
PROFIT AFTER TAXATION N593.927m N405.878m 46
BALANCE SHEET INFORMATION
FIXED ASSETS N4.034b N3.523b 15
STOCK N3.094b N2.906b 6
TRADE DEBTORS N2.110b N2.193b (4)
CASH AND BANK BALANCES N1.874b N1.211b 55
TRADE CREDITS (N3.385b) (N3.453b) (27)
OTHER CREDIT BALANCES (N968.524m) (N625.447m) 55
WORKING CAPITAL N2.726b N2.233b 22
NET ASSETS N5.977b N5.007b 19

[zainabusman]

GLAXOSMITHLINE PLC
PERIOD ENDED 30TH SEPTEMBER 2009
FORECAST PROFIT AND LOSS ACCOUNT INFORMATION
2009
TURNOVER N3.759b
PROFIT BEFORE TAXATION N554.171m
FORECAST TAXATION (N182.673m)
PROFIT AFTER TAXATION N371.498m

[zainabusman]

GLAXO SMITHKLINE CONSUMER NIGERIA PLC INTERIM REPORT FOR
THE HALF YEAR ENDED JUNE 30 2009
2009 2008
TURNOVER N7.746b N6.025b
PROFIT BEFORE TAXATION N1.744b N1.139b
TAXATION (N550.101m) (N353.242m)
PROFIT AFTER TAXATION N1.224b N786.049m
BALANCE SHEET INFORMATION
30-06-2009 31-12-2008
FIXED ASSETS N4.167b N3.961b
STOCK N3.423b N2.539b
TRADE DEBTORS N1.965b N1.917b
CASH AND BANK BALANCES N2.297b N1.192b
TRADE CREDITS N993.834m N27.493m
OTHER CREDIT BALANCES N4.759b N4.132b
WORKING CAPITAL N2.782b N2.327b
NET ASSETS N6.101b N5.451b

[zainabusman]

Originally Posted by zainabusman

GLAXO SMITHKLINE CONSUMER NIGERIA PLC INTERIM REPORT FOR
THE HALF YEAR ENDED JUNE 30 2009
2009 2008
TURNOVER N7.746b N6.025b
PROFIT BEFORE TAXATION N1.744b N1.139b
TAXATION (N550.101m) (N353.242m)
PROFIT AFTER TAXATION N1.224b N786.049m
BALANCE SHEET INFORMATION
30-06-2009 31-12-2008
FIXED ASSETS N4.167b N3.961b
STOCK N3.423b N2.539b
TRADE DEBTORS N1.965b N1.917b
CASH AND BANK BALANCES N2.297b N1.192b
TRADE CREDITS N993.834m N27.493m
OTHER CREDIT BALANCES N4.759b N4.132b
WORKING CAPITAL N2.782b N2.327b
NET ASSETS N6.101b N5.451b

It seems as if the excellent performance of beecham has gone unnoticed. Turnover went up by 28.6% and margin is 15.8% up from 13% the previous half year. PAT wet up by 55.7%!

It was also very stable during the crisis (infact it went up marginally). Anyway i have Beecham and i welcome results like this.

[horlads]

Originally Posted by zainabusman

It seems as if the excellent performance of beecham has gone unnoticed. Turnover went up by 28.6% and margin is 15.8% up from 13% the previous half year. PAT wet up by 55.7%!

It was also very stable during the crisis (infact it went up marginally). Anyway i have Beecham and i welcome results like this.

Zain,it has not gone unnoticed.@least for someone like me.i hav a copy of their annual results in my posession 4 study.i do not hv GSK and i would like to hav some.my challenge is that dis half yr result has been priced in already and i don't find it attractive @d current price. i would rather run after NAHCO than GSK for now.

[suneelkumar85]

It has recently come to our notice that some unscrupulous person(s) trying to pass off as GSK is offering jobs to individuals through e mail.

This is to caution all concerned who may receive such job offers to not get taken in by the same as such job offers are not made by GSK in India or by any other GSK entity overseas.

GSK has a standardized selection process, which includes a personal interview and a formal signed job offer in writing. No GSK company has or is offering any unsolicited job offers to persons directly in India through email. No money whatsoever is charged by GSK from candidates in return for offer of jobs. GSK will not be responsible for any action taken or commitment made in relation to such job offers and/or the consequences thereof.

Job seekers are requested to take note of the above and are advised in their own interest to refrain from responding to the job offers alleged to be made by a GSK entity. Job seekers may refer to the Career page of our website ‘gsk-india.com’ for vacancies / opportunities in GSK India.
-----------------------------------------
drug rehabilitation center
HGH

[londoncool]

I was just wondering what were the underlying factors that propelled this stock to a 49% increase since August 2009.

[savvy]

Originally Posted by londoncool

I was just wondering what were the underlying factors that propelled this stock to a 49% increase since August 2009.

Simple,
The laws of supply and demand folks are looking for a seemingly scare stock. The cache being that one hopes the demand/lack of supply is not for the purposes of manipulation

[123.rado]

05-11-2009
GLAXOSMITHKLINE PLC INTERIM REPORT FOR THE
PERIOD ENDED 30TH SEPTEMBER 2009 THIRD QUARTER
2009 2008
TURNOVER N11.373b N9.281m
PROFIT BEFORE TAXATION N2.389b N1.619b
TAXATION (N740.894m) (N502.064m)
PROFIT AFTER TAX N1.649b N1.117b
BALANCE SHEET INFORMATION 30-09-09 31-12-08
FIXED ASSETS N4.148b N3.961b
STOCK N3.786b N2.539b
TRADE DEBTORS N1.209b N942.937m
CASH AND BANK BALANCES N2.422b N1.192b
OTHER DEBIT BALANCES N605.221m N974.853m
TRADE CREDITS N1.212b N423.792m
OTHER CREDIT BALANCES N4.433b N3.736b
WORKING CAPITAL (N3.236b) (N2.327b)

[hispy99]

[http://www.proshareng.com/admin/uplo...ber%202009.pdf
GlaxoSmithKline Consumer Nigeria Plc: